Overview and Key Facts
Hypoplastic right heart syndrome (HRHS) is a rare congenital heart condition in which the right side of the heart is underdeveloped, limiting its ability to pump blood efficiently to the lungs. This overview explains the underlying anatomy, typical causes, how the condition is diagnosed, and the staged surgical treatments that manage blood flow over time. It also describes expected outcomes, long-term monitoring needs, and how families can coordinate ongoing care with a specialized team.
What Is Hypoplastic Right Heart Syndrome
HRHS is a complex congenital heart defect characterized by underdevelopment of the right ventricle, pulmonary valve, and related structures. These structural issues lead to poor blood flow from the body to the lungs, resulting in lower oxygen levels. The term hypoplastic indicates that the affected structures are smaller or poorly formed. HRHS is often identified before or shortly after birth through fetal ultrasound or early clinical signs. Management requires a multidisciplinary team that plans staged interventions to optimize circulation and oxygenation.
Anatomy Involved and How HRHS Affects Blood Flow
In a healthy heart, blood returns from the body to the right atrium, moves through the right ventricle, and is pumped to the lungs to receive oxygen. In HRHS, the right ventricle is too small, and the pulmonary valve and artery may be narrowed or absent. As a result, blood struggles to reach the lungs for oxygenation. The left side of the heart must handle both systemic and pulmonary blood flow, creating strain. This imbalance can cause cyanosis, poor growth, and breathing difficulties without medical intervention.
Structures Commonly Affected in HRHS
- Right ventricle: underdeveloped chamber that cannot pump effectively
- Pulmonary valve: often narrow or malformed, limiting outflow
- Pulmonary artery: may be hypoplastic or absent, reducing lung blood flow
- Atrial septum: may be intact or restrictive, affecting mixing of blood
Causes and Risk Factors
The exact cause of HRHS is often unknown, but it is believed to result from abnormal early heart development during the first trimester. Some cases are associated with genetic syndromes or chromosomal abnormalities, although many occur in otherwise healthy infants with no identifiable risk factors. Environmental influences and maternal health conditions may contribute in some instances, but more research is needed to fully clarify these relationships. Current evidence does not strongly support lifestyle factors as primary causes.
Diagnosis and Prenatal Detection
HRHS can sometimes be detected during a routine fetal anatomy ultrasound, particularly if the heart shows an unusual shape or size or if fluid builds up around the heart. When a suspicion arises, a fetal echocardiogram by a pediatric cardiologist provides a more detailed view. After birth, clinical signs such as bluish skin, rapid breathing, or poor feeding prompt further evaluation. Diagnostic tools may include pulse oximetry, echocardiography, electrocardiography, and chest imaging to confirm the diagnosis and guide treatment planning.
Staged Surgical Management
Because HRHS cannot be fully corrected with a single procedure, treatment follows a staged approach designed to reroute blood flow and support heart function. Each stage improves circulation and oxygen delivery, preparing the heart for the next step. Over time, the goal is to achieve satisfactory systemic and pulmonary blood flow with the available structures. The timing and sequence of surgeries are tailored to the infant’s anatomy, growth, and overall health.
Common Surgical Stages for HRHS
| Stage | Procedure | Typical Timing | Primary Goal |
|---|---|---|---|
| Stage 1 | Norwood or similar palliation | Within days to weeks after birth | Establish systemic circulation and reliable pulmonary blood flow |
| Stage 2 | Hemi-Fontan or bidirectional Glenn | Around 4–6 months of age | Reduce right heart workload and improve oxygenation |
| Stage 3 | Fontan completion | Between 18 months and 3 years of age | Direct venous return to the lungs and separate systemic and pulmonary circulations |
Long-Term Outcomes and Follow-Up
Advances in surgical and intensive care have improved survival and quality of life for many children with HRHS. Long-term outcomes depend on anatomy, surgical success, and how well the single ventricle adapts over time. Regular follow-up with a specialized cardiology team is essential to monitor heart function, rhythm, exercise capacity, and overall health. Some individuals may need additional procedures, cardiac medications, or interventions related to growth and development.
Possible Complications and Monitoring
Potential complications after staged surgeries include low oxygen saturation, arrhythmias, heart failure, protein-losing enteropathy, and issues with liver function due to chronic elevated venous pressures. Ongoing monitoring often includes echocardiography, electrocardiography, Holter monitoring, and assessments of growth and nutrition. Families are typically encouraged to work with a coordinated care team that includes cardiology, cardiology surgery, genetics, nutrition, and developmental support as needed.
Support, Resources, and Family Guidance
Families navigating HRHS often benefit from connecting with specialized centers, congenital heart networks, and peer support communities. Education about warning signs, medication management, activity guidance, and emergency planning helps caregivers feel more prepared. Genetic counseling may be recommended when relevant. As children grow, transitioning to adult congenital heart care ensures continuity and informed long-term management.